The APAC vaccines market includes the following countries: Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia, Pakistan, Philippines, Singapore, Sri Lanka, Taiwan, Thailand, and Vietnam. It is currently valued at $3 billion, with an average annual growth rate of 2% from 2012 to 2019. Rising initiatives by local governments for increasing vaccination coverage in countries such as India and China and a steadily growing patient population is likely to further boost growth of the Asia Pacific vaccines market at a CAGR of around 7.0% from 2017 to 2025.
Vaccines World 2020 aims to provide a neutral learning and networking platform to navigate the challenges faced in this industry including: R&D, Process Development & Manufacturing of Vaccines including Cancer Vaccines | Handling Pandemic Threats in Asia | Preparing for Vaccine Launches | Clinical Trials Infrastructure Challenges | Clinical Trials in Local and Global Immunotherapy Vaccines | Case Studies on Diseases such as HIV, Malaria, Dengue, Influenza, Tuberculosis, HPV | Immunization & Coverage | Vaccine Pricing & Surveillance: IP Challenges and Cost-Effectiveness of Vaccines | Complexities in Adjuvants, Delivery Systems | Global Logistical Challenges during Various Phases of Clinical Trials | Updates of Pipelines and Clinical Trial Results on Infectious Disease.
Vaccine World Asia Congress will be the only vaccine focused platform in Singapore for Asia that will bring together global partners and regional stakeholders to leverage partnership opportunities, learn about the latest technological advancements and spearhead scientific innovation. The event will play host to the BIG Pharmas, International Biopharma’s, Asian Biopharmas, Academic & Research Institutes, Regulatory Authorities, NGOs, Solution Providers and Technocrats. If Asia’s vaccines business matters to you, then Vaccine World Asia 2020 is the place to be!
Krishna Ella Bharat Biotech
Amgad Gamil Pfizer
Dong Xu CanSino Biologics
Ivana Haluskova Balter French Society of Immunology
Md Nasir Ahmed Khan Ministry of Health and Family Welfare
Wu Ke Bravovax
Sushant Sahastrabuddhe (MBBS, MPH, MBA) International Vaccine Institute
Michael Nissen GSK Vaccine R&D
Hiroyuki Shimizu National Institute of Infectious Diseases
Asel Sartbaeva University of Bath
Vaccine World Asia Congress 2020 will provide you with the opportunity to educate the market about your offerings and position yourselves as leaders in your field alongside key industry figures! This is an EXCEPTIONAL opportunity to position your brand and business before the Asia’s top vaccine executives. Make sure you get access to the region’s hottest life science sub-sector.